U.S. Cancer Diagnostics Market Overview, Industry Growth Rate, Research Report 2025-2033

United States Cancer Diagnostics Market Overview

Base Year: 2024

Historical Years: 2019-2024

Forecast Years: 2025-2034

Market Growth Rate: 8.3% (2025-2033)

Market Size in 2024: USD 53 Billion

Market Forecast in 2033: USD 108.2 Billion

The United States cancer diagnostics market is primarily driven by the rising prevalence of cancer, which has increased the demand for early detection and accurate diagnostic tools. A growing aging population, coupled with lifestyle factors such as smoking, obesity, and poor dietary habits, has contributed to a higher incidence of cancer, necessitating advanced screening techniques. Technological advancements in diagnostic methods, including liquid biopsy, next-generation sequencing, and AI-powered imaging, are improving the accuracy and efficiency of cancer detection. Additionally, the expansion of biomarker-based tests is enabling personalized medicine, allowing for more precise diagnosis and targeted treatment strategies. Government initiatives, along with private sector investments, are significantly supporting research and development in oncology diagnostics, leading to the introduction of innovative products and services. Increased awareness about cancer screening programs and preventive measures is further propelling the market, as patients and healthcare providers prioritize early intervention to improve treatment outcomes.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/united-states-cancer-diagnostics-market/requestsample

United States Cancer Diagnostics Market Trends and Drivers:

Moreover, the growing adoption of minimally invasive and non-invasive diagnostic techniques is transforming cancer detection in the U.S. market. The integration of digital pathology, automation, and telemedicine solutions is streamlining workflows, reducing diagnostic turnaround times, and enhancing patient access to specialized care. The expansion of healthcare infrastructure, particularly in outpatient and specialized cancer centers, is facilitating the widespread availability of advanced diagnostic tools. Favorable reimbursement policies and an increasing focus on value-based healthcare are encouraging hospitals and diagnostic laboratories to invest in cutting-edge technologies. The presence of major pharmaceutical and biotechnology companies in the U.S. is fostering innovation and partnerships that drive market growth. Additionally, rising healthcare expenditure and continuous funding for cancer research are enabling the development of novel diagnostic assays. The increasing prevalence of genetic testing for hereditary cancer risk assessment is also contributing to market expansion, as more individuals seek proactive screening. With ongoing advancements in precision medicine and artificial intelligence, the U.S. cancer diagnostics market is poised for continuous growth, offering improved patient outcomes and enhancing the overall efficiency of cancer care.

United States Cancer Diagnostics Industry Segmentation:

The report has segmented the market into the following categories:

Product Insights:

• Consumables
  • Antibodies
  • Kits and Reagents
  • Probes
  • Others
• Instruments
  • Pathology-Based Instruments
  • Imaging Instruments
  • Biopsy Instruments

Technology Insights:

• IVD Testing
  • Polymerase Chain Reaction (PCR)
  • In Situ Hybridization (ISH)
  • Immunohistochemistry (IHC)
  • Next-Generation Sequencing (NGS)
  • Microarrays
  • Flow Cytometry
  • Immunoassays
  • Others
• Imaging
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Positron Emission Tomography (PET)
  • Mammography
  • Ultrasound
• Biopsy Technique

Application Insights:

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Melanoma
• Others

End User Insights:

• Hospitals and Clinics
• Diagnostic Laboratories
• Others

Regional Insights:

• Northeast
• Midwest
• South
• West

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Ask Our Expert & Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=20391&flag=C

Key highlights of the Report:

• Market Performance (2019-2024)
• Market Outlook (2025-2033)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: sales@imarcgroup.com 

Tel No:(D) +91 120 433 0800 

United States: +1-631-791-1145